Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives.
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives.
复制标题
DOI:
10.3390/diagnostics11020354
复制
发表时间:
2021-02-20
期刊:
影响因子:
--
通讯作者:
Ferro M
中科院分区:
文献类型:
--
作者:
Tătaru OS;Vartolomei MD;Rassweiler JJ;Virgil O;Lucarelli G;Porpiglia F;Amparore D;Manfredi M;Carrieri G;Falagario U;Terracciano D;de Cobelli O;Busetto GM;Del Giudice F;Ferro M
Artificial intelligence (AI) is the field of computer science that aims to build smart devices performing tasks that currently require human intelligence. Through machine learning (ML), the deep learning (DL) model is teaching computers to learn by example, something that human beings are doing naturally. AI is revolutionizing healthcare. Digital pathology is becoming highly assisted by AI to help researchers in analyzing larger data sets and providing faster and more accurate diagnoses of prostate cancer lesions. When applied to diagnostic imaging, AI has shown excellent accuracy in the detection of prostate lesions as well as in the prediction of patient outcomes in terms of survival and treatment response. The enormous quantity of data coming from the prostate tumor genome requires fast, reliable and accurate computing power provided by machine learning algorithms. Radiotherapy is an essential part of the treatment of prostate cancer and it is often difficult to predict its toxicity for the patients. Artificial intelligence could have a future potential role in predicting how a patient will react to the therapy side effects. These technologies could provide doctors with better insights on how to plan radiotherapy treatment. The extension of the capabilities of surgical robots for more autonomous tasks will allow them to use information from the surgical field, recognize issues and implement the proper actions without the need for human intervention.
登录
查看更多内容
影响因子:
2.4
作者:
Chatterjee, Aritrick;Harmath, Carla;Oto, Aytekin
通讯作者:
Oto, Aytekin
影响因子:
--
作者:
Gaur, Sonia;Lay, Nathan;Turkbey, Baris
通讯作者:
Turkbey, Baris
影响因子:
3.9
作者:
Dulhanty, Chris;Wang, Linda;Wong, Alexander
通讯作者:
Wong, Alexander
影响因子:
5.9
作者:
Aldoj, Nader;Lukas, Steffen;Penzkofer, Tobias
通讯作者:
Penzkofer, Tobias
DOI:
10.1007/s00428-020-02858-w
发表时间:
2020-12
期刊:
Virchows Archiv : an international journal of pathology
影响因子:
--
作者:
Egevad L;Swanberg D;Delahunt B;Ström P;Kartasalo K;Olsson H;Berney DM;Bostwick DG;Evans AJ;Humphrey PA;Iczkowski KA;Kench JG;Kristiansen G;Leite KRM;McKenney JK;Oxley J;Pan CC;Samaratunga H;Srigley JR;Takahashi H;Tsuzuki T;van der Kwast T;Varma M;Zhou M;Clements M;Eklund M
通讯作者:
Eklund M